During the progression of arthritis, for example, Atsttrin similarly exhibited its cartilage-protective effect through both inhibiting TNFα/TNFR1-mediated inflammation and activating anabolic TNFR2 pathways [reviewed in (Wei et al., 2016)]. The gene discussed is TNFRSF1A; the disease is arthritic joint disease.